COUCHMAN JONATHAN 4
Accession 0000921895-19-000500
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:55 PM ET
Size
18.5 KB
Accession
0000921895-19-000500
Insider Transaction Report
- Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+15,500$3,875→ 4,697,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,707,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+500$125→ 4,707,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,717,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 1,569,523 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+5,000$1,250→ 1,574,523 total(indirect: By Xstelos Corp.)
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
- Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+15,500$3,875→ 4,697,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,707,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+500$125→ 4,707,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,717,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 1,569,523 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+5,000$1,250→ 1,574,523 total(indirect: By Xstelos Corp.)
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
- Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+15,500$3,875→ 4,697,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,707,166 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+500$125→ 4,707,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 4,717,666 total - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+10,000$2,500→ 1,569,523 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2019-02-11$0.25/sh+5,000$1,250→ 1,574,523 total(indirect: By Xstelos Corp.)
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
Footnotes (3)
- [F1]This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation") and Xstelos Corp. ("Xstelos" and, together with Mr. Couchman and the Foundation, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
- [F2]Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
- [F3]Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
Documents
Issuer
ENZON PHARMACEUTICALS, INC.
CIK 0000727510
Related Parties
1- filerCIK 0001265094
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:55 PM ET
- Size
- 18.5 KB